Literature DB >> 17389174

Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells.

Kwou-Yeung Wu1, Hwei-Zu Wang, Show-Jen Hong.   

Abstract

In this study, the various antiglaucoma drugs including betaxolol, timolol, levobunolol, carteolol, brimonidine, dipivefrin, dorzolamide, brinzolamide, latanoprost, unoprostone, and pilocarpine were used to investigate the effects of cellular cytotoxicity in cultured bovine corneal endothelial cells. After exposure to the drugs in three dilutions, 1/100, 1/1,000, and 1/10,000, for 100 minutes, cells were estimated based on the release assay of lactate dehydrogenase (LDH) enzyme. It was found that cellular LDH was significantly released in the medium only at 1/100th dilution of betaxolol, brimonidine, dorzolamide, dipivefrin, latanoprost and unoprostone to 130%, 123%, 145%, 157%, 128% and 237%, respectively, compared with controls upon exposure to drugs for 100 minutes. Moreover, benzalkonium chloride preservative at the concentrations ranging from 0.001 to 0.00001 mg/mL did not affect cellular LDH release in bovine corneal endothelial cells. These results indicate that high concentrations of antiglaucoma drugs may induce cytotoxicity in corneal endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389174     DOI: 10.1016/S1607-551X(09)70384-5

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  9 in total

1.  Cytotoxic effects of betaxolol on healthy corneal endothelial cells both in vitro and in vivo.

Authors:  Ying Miao; Qian Sun; Qian Wen; Yue Qiu; Yuan Ge; Miao-Miao Yu; Ting-Jun Fan
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  Apoptosis in the iris and trabecular meshwork of medically treated and untreated primary open angle glaucoma patients.

Authors:  Zeynep Aktas; Emine Esra Karaca; Ipek Işik Gonul; Murat Hasanreisoglu; Merih Onol
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

3.  Corneal Endothelial Cell Density in Normal Tension Glaucoma Compared to Healthy Controls.

Authors:  Jia Xu; Manishi A Desai; Hyunjoo J Lee
Journal:  J Clin Med       Date:  2022-06-18       Impact factor: 4.964

4.  Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells.

Authors:  Dorota Pozarowska; Piotr Pozarowski; Zbigniew Darzynkiewicz
Journal:  Cytometry B Clin Cytom       Date:  2010-03       Impact factor: 3.058

5.  Changes in corneal parameters at confocal microscopy in treated glaucoma patients.

Authors:  Stefano Ranno; Paolo Fogagnolo; Luca Rossetti; Nicola Orzalesi; Paolo Nucci
Journal:  Clin Ophthalmol       Date:  2011-07-26

6.  Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.

Authors:  David A Ammar; Malik Y Kahook
Journal:  Mol Vis       Date:  2011-07-02       Impact factor: 2.367

7.  Factors affecting the corneal endothelium after selective laser trabeculoplasty in primary open angle and angle closure glaucoma.

Authors:  Natalia Ivanovna Kurysheva; Lyudmila Vyacheslavovna Lepeshkina; Svetlana Georgievna Kapkova
Journal:  BMJ Open Ophthalmol       Date:  2021-04-27

8.  Mid-Term Evaluation of iStent Inject® Trabecular Micro-Bypass Stent Implantation with or without Phacoemulsification: A Retrospective Study.

Authors:  Regina Cele Silveira Seixas; Marcos Balbino; Alberto Basile Neto; Amanda de Alcantara Almeida Costa; Marcelo Lopes da Silva Jordão; Heloisa Helena Abil Russ
Journal:  Clin Ophthalmol       Date:  2020-12-16

9.  Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms.

Authors:  Wen Su; Jun Zhao; Ting-Jun Fan
Journal:  Front Pharmacol       Date:  2020-03-06       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.